Next-generation sequencing and biomarkers for gastric cancer: what is the future?
Recent years have witnessed an improved understanding of tumour biology and the molecular features of gastric cancer. Remarkable advances in next-generation sequencing technologies have defined the genomic landscape of gastric cancer. In fact, several molecular classifications have been proposed, an...
Main Authors: | Akihito Kawazoe, Kohei Shitara |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-06-01
|
Series: | Therapeutic Advances in Medical Oncology |
Online Access: | https://doi.org/10.1177/1758835919848189 |
Similar Items
-
Tuberculous Meningitis during Chemotherapy for Advanced Gastric Cancer
by: Hiroshi Matsumoto, et al.
Published: (2018-04-01) -
Molecular and pathological analyses of gastric stump cancer by next-generation sequencing and immunohistochemistry
by: Masahiro Watanabe, et al.
Published: (2021-02-01) -
Retrospective cohort study of nanoparticle albumin-bound paclitaxel plus ramucirumab versus paclitaxel plus ramucirumab as second-line treatment in patients with advanced gastric cancer
by: Mashiro Okunaka, et al.
Published: (2020-11-01) -
Next-Generation Sequencing: Application in Liver Cancer—Past, Present and Future?
by: Jesper B. Andersen, et al.
Published: (2012-08-01) -
Trastuzumab deruxtecan for the treatment of patients with HER2-positive gastric cancer
by: Daisuke Kotani, et al.
Published: (2021-01-01)